Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study).
暂无分享，去创建一个
R. Berardi | S. Cascinu | C. Pinto | S. Siena | C. Ceccarelli | F. Di Fabio | L. Giannetta | A. Martoni | S. Giaquinta | V. Mutri | F. R. Llimpe | E. Piana | F. Fabio | C. Funaioli | C. Longobardi | F. R. Rojas Llimpe